Class B guanine nucleotide-binding protein (G protein)-coupled receptors form symmetrical homodimeric complexes along the lipid face of transmembrane segment 4 (TM4) and can form heterodimeric complexes, although their structure is unknown. The current study demonstrates that the lipid face of TM4 is also the predominant determinant for formation of heteroreceptor complexes between two class B receptors, secretin receptor (SecR) and glucagonlike peptide-1 receptor (GLP-1R), which are expressed on pancreatic islet cells. Because these receptors use the same interface for formation of homo-and heteroreceptor complexes, competitive forces may affect expression of different complexes. Assessment of SecR and GLP-1R dimeric complexes via recombinant expression in Chinese hamster ovary cells revealed that homodimeric receptor complexes were more stable than the heterodimeric complexes, and the homodimeric SecR/SecR is more stable than the GLP-1R/GLP-1R complex. Given the greater tendency for homodimeric compared with heterodimeric complex formation, the heteroreceptor complexes lacked the expression that might have been predicted by geometry alone. Nevertheless, cells coexpressing these receptors formed heterodimeric complexes that correlated with reduced intracellular calcium responses to secretin, but no change in the cyclic adenosine monophosphate responses to each natural agonist. This functional effect was confirmed in pancreatic islets isolated from wild-type and GLP-1R knockout mice. In these cells, the increased calcium response mediated by secretin in the absence of GLP-1R was paralleled by an increased glucose-dependent insulin response, indicating that the heterodimeric receptor complexes modulate secretin responses. Furthermore, the heterodimeric receptor complexes also mediated agonist-induced cross-receptor internalization, a process that could have broad functional significance in sites of natural receptor coexpression. (Endocrinology 158: 1685(Endocrinology 158: -1700(Endocrinology 158: , 2017 G uanine nucleotide-binding protein (G protein)-coupled receptors (GPCRs) are the largest superfamily of cell surface receptors in the body, present on every regulatable cell and positioned to mediate the effects of extracellular hormones and neurotransmitters on intracellular effector pathways and cellular responses.
G uanine nucleotide-binding protein (G protein)-coupled receptors (GPCRs) are the largest superfamily of cell surface receptors in the body, present on every regulatable cell and positioned to mediate the effects of extracellular hormones and neurotransmitters on intracellular effector pathways and cellular responses.
The heptahelical transmembrane segment topology is responsible for the hydrophobic nature of these molecules and their ability to associate, particularly when overexpressed in the plasma membrane. This characteristic has been responsible for much of the controversy about the physiological nature of GPCR oligomerization and the need for well-controlled studies of this phenomenon, including variation of protein expression (1) . Nevertheless, there is now general agreement that at least a subset of GPCRs associate to form dimeric or higher-order oligomeric complexes within the plasma membrane (2); these complexes can be responsible for functional changes in ligand binding, signaling, and/or regulation of receptor trafficking (3) . Class C GPCRs are obligate dimers; some complexes are even disulfide bonded (4) . For the class A GPCRs, oligomeric complexes for some members have been shown to exist transiently (5) , with a broad spectrum of tendencies to associate across this receptor family (2) .
Similarly, most class B GPCRs are capable of forming symmetrical homodimeric complexes that are mediated by the lipid face of transmembrane segment 4 (TM4) (6, 7) . Homodimeric complexes of class B GPCRs can mediate negative cooperativity of natural ligand binding and action, and can also mediate the high affinity and highpotency action of the natural ligand binding to one of the receptor protomers (8) . Heterodimeric complexes of class B GPCRs have also been reported (9) (10) (11) (12) (13) (14) ; some of these complexes are able to affect signaling and receptor regulatory events, such as internalization. To date, however, reported studies have been confined to recombinant expression systems, and the physiological significance of this phenomenon remains unclear. Furthermore, reports on the functional impact of coexpression of more than one class B GPCR have been inconsistent (12, 13) , and this likely reflects the particular cellular systems being studied. One potentially important variable that has not been explored is the stoichiometric ratio of expression of two class B GPCRs and the impact on formation of various complexes.
Several members of this receptor family have been shown to use the same TM4 interface as the dominant determinant for homodimerization (6, 7, 15) , and this is likely to be more broadly true across class B GPCRs. We postulated that this interface also represents the key determinant for cross-receptor association of these structurally related molecules. In the current work, we examined this directly, focusing on two class B GPCRs reported to be coexpressed on pancreatic islet cells, the glucagonlike peptide-1 (GLP-1) receptor (GLP-1R) (16) and the secretin receptor (SecR) (17) , although the level of SecR expression in islets is quite low (18) . However, convincing data have been reported to show that isolated perfused islets secrete insulin in response to secretin (19, 20) .
Much of this work was performed using carefully regulated receptor-expressing model cell systems. We have used receptor bioluminescence resonance energy transfer (BRET) as a measure of receptor association, demonstrating that heteroreceptor complexes can form between the GLP-1R and SecR receptors, and that this process also utilizes the lipid face of TM4 as the dominant interface. To further explore the relative tendency of these receptors to self-associate and to cross-associate, we established a series of model cell lines that express equal numbers of SecR and GLP-1R, and also cell lines that express the same density of SecR on cells expressing fewer and greater numbers of GLP-1Rs. Formation of heterocomplexes was paralleled by reduction in intracellular calcium responses to secretin, although cyclic adenosine monophosphate (cAMP) signaling mediated by the natural agonists was not altered. Using cells expressing fluorescently tagged receptors, alone or together, we demonstrated cross-internalization stimulated by each natural agonist ligand that occurred only when both receptors were coexpressed. The functional impact of SecR-GLP-1R complexes on signaling events was confirmed in pancreatic islets that naturally express both receptors.
Materials and Methods

Materials
Sources of specialized reagents were the following: molecular biology reagents (New England BioLabs, Ipswich, MA); coelenterazine h (QT, Hayward, CA); cAMP assay kits using LANCE technology and Optiplates (PerkinElmer, Wellesley, MA); Quest Fluo-8 AM (AAT Bioquest, Sunnyvale, CA); polyethyleneimine (Polysciences, Warrington, PA); VECTA-SHIELD (Vector Laboratories, Burlingame, CA); black clearbottom 96-well tissue culture plates (Corning); Ham's F-12, Opti-MEM, L-glutamine, minimum essential medium, Dulbecco's modified Eagle medium, and zeocin (Invitrogen, Carlsbad, CA); FetalClone II supplement (HyClone Laboratories, Logan, UT); Connaught Medical Research Laboratories (CMRL) medium (Life Technologies); ponasterone A (Santa Cruz Biotechnology, Dallas, TX); RNeasy (Qiagen, Frederick, MD); Taqman probes (ThermoFisher Scientific, Waltham, MA); and collagenase P (Roche Molecular Biochemicals, Indianapolis, IN). Other reagents were analytical grade.
Ligands and radioligands
Secretin (1-27) (secretin) and its analogs were synthesized in our laboratory and purified to homogeneity by reversed-phase high-performance liquid chromatography; identities were confirmed by mass spectrometry (21) . Human glucagonlike peptide-1(7-36)-amide (GLP-1) was purchased from American Peptide (Sunnyvale, CA). Radioligands, 125 I-[Tyr 10 ]-secretin and 125 I-GLP-1(7-36) -amide, were prepared in our laboratory by oxidative radioiodination using IODO-BEADS (Pierce Chemical, Rockford, IL), and purified to homogeneity by reversed-phase high-performance liquid chromatography to yield specific radioactivities of approximately 2000 Ci/mmol.
Receptor constructs
Human GLP-1 and SecR constructs [wild-type (WT) and mutant SecR and GLP-1R] tagged with either Renilla luciferase (Rlu) or yellow fluorescent protein (YFP) at their carboxyl terminus were subcloned into pcDNA 3.0 expression vector.
Functional characterization of these constructs has shown that they bind their respective radioligands specifically and saturably (6, 7), and they are able to elicit full biological responses (6, 7) . The untagged receptor constructs were subcloned either into pcDNA 3.0 or pcDNA 3.0/Zeo + expression vectors, and sequences were confirmed by DNA sequencing. The YFP-tagged GLP-1R construct was also subcloned into the inducible expression vector, pEGSH (Agilent Technologies, Santa Clara, CA). All constructs were directly sequenced to verify their identities.
Cell lines and culture
African green monkey kidney (COS-1) cells were used for transient expression of the receptor constructs used for the BRET studies, due to the large number of conditions used in such studies. Cells were seeded in 10-cm tissue culture dishes in Dulbecco's modified Eagle medium media supplemented with 5% FetalClone II (HyClone Laboratories) and 100 IU/mL penicillin-100 mg/mL streptomycin. After 24 hours and at approximately 80% confluence, the cells were transiently transfected with 1 mg of donor and 1 mg of acceptor constructs in the presence or absence of increasing concentrations of untagged receptor constructs (0.5 to 8.0 mg) using the diethylaminoethyl-dextran method, as described previously (22) .
For functional studies, stable receptor-expressing cell lines, in which levels of expression of each relevant receptor were carefully controlled, were established in the background of Chinese hamster ovary (CHO) cells. Parental CHO cells not expressing either relevant receptor (SecR or GLP-1R) were grown to approximately 75% confluence prior to transfection with relevant receptor complementary DNA (cDNA) (tagged or untagged SecR and GLP-1R constructs) and polyethyleneimine (1 mg/mL) in Opti-MEM medium (Invitrogen) (23) . The stable transfectants were selected using either G-418 (1 mg/mL) or zeocin (0.5 mg/mL; Invitrogen), as appropriate, and clones were selected using limiting dilution. Receptor expression levels were measured using radioligand binding assays.
Cells expressing similar numbers of SecR and GLP-1R were chosen for these studies. For the dual-expressing cell lines, the SecR-expressing cell line was subsequently transfected with the GLP-1R construct, and zeocin-resistant clones were selected by limiting dilution. A series of coexpressing cells were chosen on the basis of their levels of similar, higher, and lower levels of GLP-1R expression. A cell line expressing similar levels of SecR and the TM4 mutant of GLP-1R known to interfere with receptor dimer formation was also prepared. These cell lines were grown in tissue culture flasks containing Ham's F-12 medium (Invitrogen) supplemented with 5% FetalClone II (HyClone Laboratories) in a humidified environment containing 5% carbon dioxide. Cells were passaged approximately two times per week.
Another CHO cell line, coexpressing tagged versions of both SecR and GLP-1R for additional special BRET studies requiring distinct receptor densities, was also prepared. This line stably expressed a fixed amount of Rlu-tagged SecR and an inducible amount of YFP-tagged GLP-1R. Ponasterone A was used to induce the expression of the latter receptor, varying both the concentration (2 to 12 mM) and duration of treatment (up to 18 hours) of the inducing agent. The levels of SecR and GLP-1R expression were determined on the basis of radioligand binding characterization that was performed on intact cells.
CHO cell lines expressing approximately the same density of SecR as the previously described SecR plus inducible-GLP-1R-bearing cell line were also prepared, with approximately half of the SecR tagged with Rlu and half tagged with YFP. This was performed to gain insights into the homoreceptor BRET signal that would come from this density of SecR in the absence of competing GLP-1R. Although this approach could only provide an approximation, the result would provide insight into the percentage of homoreceptor complexes that might be disrupted to produce the heteroreceptor complexes. For internalization studies, human embryonic kidney 293 cells (HEK293) were transiently transfected with either YFP-tagged SecR or YFP-tagged GLP-1R in the presence and absence of complementary untagged receptor, as described later.
BRET studies
BRET studies requiring a large number of different conditions were performed using transient receptor expression in COS-1 cells, rather than establishing multiple stable CHO cell lines. As we described previously, the COS-1 cells are easily transfected and reliably and reproducibly yield levels of expression that reflect the amount of DNA used (24) . Cells expressing tagged receptor constructs were used for bioluminescence and fluorescence measurements in white 96-well Optiplates (PerkinElmer) (24) . In brief, cells were transfected with 1 mg cDNA of each donor and acceptor construct, along with increasing amounts of untagged receptor construct, as described. Forty-eight hours after transfection, BRET studies were initiated by mixing the cell suspension (25,000 cells per well) with 5 mM coelenterazine h (QT) (Rlu-specific substrate) at room temperature. Rlu-and YFP-emission signals were collected immediately after adding coelenterazine h using a 2103 EnVision fluorescence plate reader (PerkinElmer) configured with a ,700 nm mirror and dual-emission filter sets for luminescence (460 nm; bandwidth of 25 nm) and fluorescence (535 nm; bandwidth of 25 nm). BRET ratios were calculated on the basis of the ratio of YFP and Rlu emissions (24) . Background levels of BRET were determined using coexpression of either soluble partner to the donor and/or acceptor or by coexpressing a structurally unrelated GPCR. The range in BRET-from this background to the maximal BRET signal between donor and acceptor-was considered the range of signal that was competed for with the expression of untagged receptor. Additionally, similar special BRET assays requiring distinct receptor densities were performed using the stable tagged receptor-bearing cell lines described previously, without the need to transfect those cells.
Saturation BRET studies were also performed as we described previously, utilizing COS-1 cells (6). Cells were transfected with a fixed concentration of one Rlu-tagged construct (0.75 mg DNA per dish) and increasing amounts of the complementary YFP-tagged construct (0.15 to 3.0 mg DNA per dish). Forty-eight hours after transfection, the cells were detached and their fluorescence and luminescence signals were collected. Background-subtracted intensities were used to calculate the acceptor-to-donor ratios that were plotted against the BRET ratios. Curves were fit to these data and were evaluated for differences relative to a linear function using R 2 values; P , 0.05 was considered to be significant. incubated with approximately 2 pM secretin or GLP-1 radioligand in the absence and presence of increasing concentrations of unlabeled secretin or GLP-1 peptide, respectively, in KrebsRingers-HEPES (KRH) medium (25 mM HEPES; pH, 7.4; 104 mM NaCl; 5 mM KCl; 2 mM CaCl 2 ; 1.0 mM KH 2 PO 4 ; 1.2 mM MgSO 4 ) at room temperature for one hour. At the end of this incubation, the receptor-bound fraction was separated from free radioligand by washing the cells with ice-cold KRH medium, and cells were lysed with 0.5 M NaOH. The residual radioactivity in the lysate was quantified by g counter. Detectable radioactivity in the presence of 1 mM unlabeled ligand was used to determine nonsaturable binding. Data were analyzed using the LIGAND program developed by Munson and Rodbard (25) , and were graphed using the nonlinear leastsquares curve-fitting routine in Prism 6 (GraphPad, San Diego, CA).
Intracellular calcium assays in receptor-bearing CHO cell lines
Agonist-stimulated intracellular calcium responses were measured in receptor-expressing intact cells, as described previously (26) . Cells were seeded in a black clear-bottom 96-well plates (PerkinElmer) 24 hours prior to assay and allowed to reach 80% confluence. The cells were then washed and incubated with 0.75 mM Quest Fluo-8 AM (AAT Bioquest) (dissolved in dimethyl sulfoxide) in KRH medium containing 2.5 mM probenecid and 0.2% bovine serum albumin for one hour at 37°C in the dark. Incubations were terminated by aspirating the medium and washing the cells. The assay was performed in a FlexStation 3.0 plate reader (Molecular Devices, Sunnyvale, CA) having the capability of automated addition of the appropriate ligand. The intracellular calcium responses were initiated by addition of various concentrations of agonist up to 1 mM at 37°C. Responses were quantified on the basis of fluorescence emission intensities at 525 nm after exciting the samples at 485 nm; data were collected every four seconds over a 120-second period. Data were plotted using Prism 6 (GraphPad), and peak responses were identified and quantified.
cAMP assays in receptor-bearing CHO cell lines
Agonist-stimulated cAMP accumulation in receptor-bearing cells was quantified using the LANCE assay kit (PerkinElmer) with 384-well white Optiplates (PerkinElmer) and a 2103 EnVision plate reader (PerkinElmer), as described previously (6) . Receptor-bearing cells were seeded 24 hours before the assay in sterile 96-well plates (PerkinElmer) and were allowed to reach approximately 80% confluence. Cells were then stimulated with increasing concentrations with either secretin (up to 100 nM) or GLP-1 (up to 100 nM) in KRH medium (pH 7.4) containing 0.2% bovine serum albumin, 0.01% soybean trypsin inhibitor, 0.1% bacitracin, and 1 mM 3-isobutyl-1-methylxanthine for 30 minutes at 37°C. After the incubation, the assay was terminated by adding 6% ice-cold perchloric acid, and the pH was adjusted to 6.5 using 30% KHCO 3 . cAMP responses were quantified by mixing 6 mL of cell supernatant and cAMP antibodies labeled with Alexa Fluor 647 (ThermoFisher Scientific) and incubating for 30 minutes at room temperature. The reaction mixture was then mixed with 12 mL of detection solution containing biotin-cAMP and europium-labeled streptavidin. Time-resolved fluorescence resonance energy transfer signals were acquired in a 2103
EnVision plate reader (PerkinElmer) using excitation at 340 nm, with emission measured at 615 and 665 nm wavelengths.
Receptor internalization studies
Receptor internalization studies were performed in HEK293 cells, because of the quality of morphologic studies and ease in defining intracellular compartments in these cells, rather than using the small round CHO cell lines. Cells expressing YFPtagged SecR or YFP-tagged GLP-1R alone or in conjunction with the complementary untagged receptor, GLP-1R or SecR, respectively, were washed twice with phosphate-buffered saline (PBS), pH of 7.4, and incubated with 10 nM agonist ligand (secretin or GLP-1) at 4°C for 90 minutes in PBS containing 0.08 mM CaCl 2 and 0.1 mM MgCl 2 . This provided adequate time for the natural agonist ligand to occupy all surface receptors. The cells were then washed with ice-cold PBS and moved to 37°C. At each time point after warming, the cells were fixed with 2% paraformaldehyde, washed twice with PBS, and then mounted on slides using VECTASHIELD (Vector Laboratories).
Low-power images were examined to determine the percentage of cells that were responsive to ligand-induced tagged receptor internalization after warming for 30 minutes. For this, images were acquired with an Axio Imager (20 3 0.8 NA, Axiocam 105 color camera, fluorescein isothiocyanate channel, Zen2 program), and cells were scored manually on the basis of whether the predominant pattern of fluorescence was at the cell surface or internalized. Approximately 100 cells were scored for each condition in a minimum of three experiments.
Tagged-receptor fluorescence was also imaged using a Zeiss LSM510 confocal microscope (Carl Zeiss Microscopy, Thornwood, NY; pinhole diameter of 225 mm with planapochromat 63 3 1.4 numerical aperture oil objective) configured to capture YFP (excitation, 488 nm; emission, 500 to 550 nm band-pass filter; pinhole, 220 mm). Quantitative morphometric analysis of receptor internalization over time was performed using Image J (National Institutes of Health, Washington, DC) to determine fluorescence density at the cell surface relative to total cellular fluorescence. Signals were corrected for background fluorescence. Quantitation was performed for approximately 100 cells for each condition, with more than 20 cells quantified at each point in time after warming. The fluorescence at the plasma membrane at time zero was normalized to 100% of surface receptors.
Ex vivo mouse studies
All mice were bred and maintained at the Monash Institute of Pharmaceutical Sciences animal facilities (Parkville, Australia) in accordance with the Monash University Animal Ethics Committee, who approved all experimental procedures. Male C57BL6/NTac and GLP-1R-null [GLP-1R( 2/2 )] mice at 8 to 12 weeks of age were used for pancreatic islet isolation. C57BL6/NTac were from TaconicArtemis (Cologne, Germany), and GLP-1R( 2/2 ) mice were generated on this C57BL6/ NTac background at Taconic, as previously reported (27) .
Pancreatic islet isolation
Mouse pancreatic islets were isolated by digestive enzyme treatment, as previously described (28) . The common bile duct was cannulated, and the pancreas was distended with 3 mL of Hank's balanced salt solution containing 1.3 U/mL collagenase P (Roche Molecular Biochemicals). Distended pancreata were digested at 37°C for 16 minutes and were then disrupted by vigorous shaking for one minute. Islets were purified on a Histopaque-1077 density gradient (Sigma-Aldrich, St. Louis, MO) (29) . Purified islets were washed, handpicked, and cultured with CMRL medium 1066 (Life Technologies) supplemented with 10% fetal bovine serum, 2 mM glutamine, and 100 IU/mL penicillin/streptomycin at 37°C in 5% CO 2 incubator.
Messenger RNA isolation and real-time polymerase chain reaction Total RNA was isolated from mouse islets using RNeasy Mini Kit (Qiagen), as per the manufacturer's protocol. Briefly, on day 1 after isolation, 150 to 200 intact islets per animal were handpicked and washed with PBS prior to digestion with 350 mL Buffer RLT (1% b-mercaptoethanol; Qiagen) and snap freezing in liquid nitrogen. RNA was extracted and purified as per the manufacturer's protocol with total RNA eluted in 20 mL RNase-free water. Eluted RNA was quantified using a NanoDrop (ThermoFisher Scientific). Ribosomal bands (18S and 28S) were also assessed on a 1% agarose gel.
SecR messenger RNA expression was quantified using Taqman probes from ThermoFisher Scientific (FAM-Mm01290788_m1; catalog no. 4448892). The housekeeping gene b-actin was used as a control (FAM-Mm02619580_g1; catalog no. 4331182). cDNA was generated using the iScript Reverse Transcription Supermix kit (Bio-Rad) with 500 ng total RNA in a final 10-mL reaction volume. The reaction was primed at 25°C for five minutes, reverse transcribed at 42°C for 30 minutes, and inactivated at 85°C for five minutes. The expression level of a gene of interest was quantified by polymerase chain reaction (PCR) using an Eppendorf Realplex MasterCycler. cDNA was amplified using TaqMan Fast Advanced Master mix (ThermoFisher Scientific) with 200 ng (secretin receptor/b-actin) RNA over 40 cycles. The reaction was first heated to 50°C for two minutes, followed by activation of 96°C for 10 minutes prior to 40 PCR cycles (denatured at 95°C for 15 seconds; an annealing step at 60°C for one minute). Expression levels were expressed as cycle threshold value for each gene of interest.
Insulin secretion assays
Glucose-stimulated insulin secretion assays were performed on intact mouse islets that were size matched using three islets per experimental replicate. Islets were glucose starved for two hours in 2.8 mM glucose in Earle's balanced salt solution (EBSS) followed by peptide or vehicle stimulation in EBSS supplemented with high glucose (final, 16.7 mM) for two hours at 37°C in a 5% CO 2 incubator. Supernatants were collected and insulin levels were detected using a Homogeneous TimeResolved Fluorescence Insulin kit (Cisbio Bioassays), according to the manufacturer's instructions.
cAMP assays in mouse pancreatic islets cAMP assays were performed on intact mouse islets that were size matched using five islets per experimental replicate. Islets were glucose starved for two hours in 2.8 mM glucose EBSS buffer. Peptide-mediated cAMP production was detected using the PerkinElmer LANCE cAMP kit. Islets were placed in a 384-well OptiPlate in 2.8 mM glucose and combined with peptide or vehicle (in EBSS with 2.8 mM or 16.7 mM glucose) at 37°C in 5% CO 2 for 30 minutes in the presence of isobutyl-1-methylxanthine and anti-cAMP antibody (total volume of 12 mL). Plates were snap frozen to terminate the reaction. Twelve microliters of detection buffer containing Eu-cAMP tracer (1:2250 dilution) and biotin cAMP (1:1500) were added and incubated for one hour. Homogeneous time-resolved fluorescence for each sample was detected using an EnVision plate reader (PerkinElmer) with excitation at 320 nm and emission at 615 nm. cAMP was determined for all samples via conversion to concentration of cAMP using a cAMP standard curve that was detected in parallel. Forskolin (100 mM) was used as a positive control.
Calcium mobilization in mouse pancreatic islets
Calcium mobilization assays were conducted on dissociated mouse islet cells. Freshly isolated islets were dissociated into single cells with bovine trypsin (342 U/mL, 2 mM EDTA) digestion for five minutes at 37°C. Dissociated islet single cells were seeded at 25,000 cells per well in half-area 96-well plates precoated with 5 mg/mL laminin, in CMRL medium supplemented with 11 mM glucose, 10% fetal bovine serum, 2 mM glutamine, and 100 IU/100 mg/mL penicillin/streptomycin at 37°C in a 5% CO 2 incubator. Four days after culture, dissociated islet cells were serum starved in Roswell Park Memorial Institute medium (0.5% bovine serum albumin and 2.8 mM glucose) overnight. The next morning, dissociated islet cells were washed twice with EBSS (containing 2.8 mM glucose, 0.1% bovine serum albumin, and 1.8 mM CaCl 2 ) followed by 45 minutes of incubation with 1 mM Fluo-4 AM (AAT Bioquest) and 4 mM probenecid prior to the addition of peptide agonist or vehicle in a FlexStation (Molecular Devices). Peptides and vehicle were prepared in EBSS supplemented with glucose to give final glucose concentrations of 2.8 mM or 16.7 mM in the assay. Fluorescence was determined immediately after peptide addition, with an excitation/emission wavelength set at 485/520 nm. Readings were taken every 1.36 seconds for 180 seconds. The area under the curve was calculated using fivepoint smoothing, followed by correction against basal fluorescence. Data were normalized to the maximal response elicited by ionomycin (1 mM).
Statistical analysis
Differences for each experimental condition were evaluated using Student t test or one-way analysis of variance analysis with Dunnetts's multiple comparison test using Prism 6 (GraphPad). A P value of ,0.05 was considered to be statistically significant.
Results
TM4 is required for formation of heteroreceptor complexes between SecR and GLP-1R
Static receptor BRET studies confirmed previous reports (6, 7, 10) of the ability of SecR and GLP-1R to form both homoreceptor complexes and heteroreceptor complexes when constructs were expressed transiently in COS cells (Fig. 1) . Consistent with previous studies, mutants of these receptors involving the lipid face of TM4 were able to disrupt the homoreceptor complexes. This same molecular interface was required for heteroreceptor association for these two class B GPCRs [ Fig. 1(a) ]. Using saturation BRET studies, we also confirmed that this association event is relevant to low levels of receptor expression [ Fig. 1(b) ].
Receptor competition studies to define stability of complexes Shown in Fig. 2(a-f) are the absolute BRET ratios observed when equal amounts of complementary tagged receptor cDNA constructs were expressed in COS-1 cells in the absence or presence of increasing amounts of untagged receptor cDNA constructs. In addition, BRET ratios are shown for a complementary soluble tag or structurally unrelated complementary tagged cell surface receptor. These latter two conditions establish the background BRET signal that could be expected in each series of experiments. A control using transfection of an empty vector added in similar amounts to the competing receptor constructs had no effect on the BRET ratio [ Fig. 2(g) ]. It is noteworthy that, in every case, the homodimeric complexes were more stable than the heterodimeric complexes. Free monomer (either one) was able to disrupt the heterodimers more efficiently than the homodimers [ Fig. 2 (h) and 2(i)], thereby facilitating the formation of homodimers when unequal amounts of each receptor were present on a given cell. The heterodimeric complex was most easily disrupted, followed by the GLP-1R homodimeric complex, and the SecR homodimeric complex was the most difficult to disrupt. The same rank order was observed for the ability of SecR and GLP-1R to disrupt these complexes.
Heteroreceptor BRET saturates at an approximate 1:1 stoichiometry of SecR to GLP-1R
To better understand the data in the COS cell lines expressing different amounts of these two receptors, we prepared a stable CHO cell line that expressed a fixed amount of SecR-Rlu and a variable amount of GLP-1R-YFP (utilizing an inducible promoter). This cell line expressed a lower number of SecR than the other stable CHO lines used in the functional characterization studies (discussed later), on the basis of the direct analysis of cell surface receptor expression by radioligand binding. The negative logarithm of the equilibrium dissociation constant (pK i ) was 8. 
Functional characterization of CHO cell lines coexpressing SecR and GLP-1R
Shown in Fig. 4 are competition-binding curves for secretin and GLP-1 for their respective radioligands (binding parameters are listed in Table 1 ). As expected, the CHO cell lines expressing the same density of SecR in the absence or presence of different amounts of GLP-1R exhibited similar competition-binding curves [ Fig. 4(a) ]. In the binding curves for GLP-1, the amount of radioligand bound (B max ) correlated with the levels of expression of GLP-1R [ Fig. 4(b) ]; however, GLP-1 pK i values did not significantly change in these matched cell lines (Table 1 ). Biological responses to GLP-1 and secretin were also assessed for these cell lines ( Fig. 5 ; Table 2 ). The maximal cAMP responses for secretin and GLP-1 in receptors expressing similar levels of these receptors were similar to each other [ Fig. 5(a) and 5(b) ]. Secretin-stimulated cAMP concentration response curves were not significantly different in the absence or presence of differential stoichiometry of GLP-1R expression (although, due to variability in some experiments, the mean value for the SecR/ low-expressing GLP-1R line was lower than for the other lines) [ Fig. 5(a) GLP-1) . In contrast, the potency of secretin to stimulate intracellular calcium responses was reduced when SecR was coexpressed with equal or higher levels of GLP-1R (and these curves did not reach a plateau at 1 mM secretin). This reduction in secretin-stimulated calcium responses was not observed in a cell line expressing similar levels of SecR or when SecR was expressed with the TM4 mutant of GLP-1R [ Fig. 5(c) ], supporting a role for direct interaction between these two receptors. Table 2 summarizes the quantitative parameters for these functional responses. In control experiments, secretin did not elicit any intracellular calcium response in cells expressing the GLP-1R, and GLP-1 did not elicit any intracellular calcium response in cells expressing the SecR (data not shown).
Agonist-induced internalization of receptors in the heteroreceptor complex
HEK293 cells expressing fluorescently tagged SecR or GLP-1R, in the absence or presence of expression of the complementary receptor, were used to examine agoniststimulated receptor internalization (Figs. 6-7) . As reported previously (30, 31) , both natural ligands stimulated the internalization of their respective receptors. This was true both when they were expressed alone on the cell surface and when they were coexpressed with the complementary class B GPCR. Of particular interest, in each condition, the occupation of one of these interacting receptors with their natural ligand also stimulated the internalization of the complementary receptor. This was visualized when the cells coexpressing fluorescently tagged SecR and untagged GLP-1R were stimulated with GLP-1, and when those coexpressing fluorescently tagged GLP-1R and untagged SecR were stimulated with secretin.
Secretin stimulated the same percentage of cells to internalize tagged SecR when it was expressed alone or in Using quantitative morphometry, we also determined the time course of internalization of the cell surface fluorescence signal, representing tagged receptors, under each condition. The receptor internalization was similar both in quantity and in the kinetics (time course) for each condition in which receptor internalization was observed (Fig. 7) . This included the agonist-occupied receptor and those unoccupied when they were coexpressed with the complementary class B GPCR that was occupied by its natural agonist ligand. The same receptor, when unoccupied and expressed alone, exhibited no significant internalization response to the opposite natural agonist ligand.
Heterodimerization is physiologically important in mouse pancreatic islets
To further assess the relevance of SecR-GLP-1R heterodimerization and the effect of this relative to homodimerization on receptor functional outputs, we assessed responses to secretin and GLP-1 in primary mouse pancreatic islets isolated from WT and from GLP-1R( 2/2 ) animals ( Fig. 8) . Real-time PCR analysis revealed very low levels of SecR messenger RNA expression that was similar in both WT and GLP-1R( 2/2 ) animals
[ Fig. 8(a) ]. This is consistent with what was previously reported, with SecR expression too low to be identified by receptor autoradiography (18) . In WT islets, expression levels of the GLP-1R were much higher than SecR (with a cycle threshold value of 26.5 6 0.8). The primary cells therefore represent a situation in which SecR may be present predominantly as a heterodimer, because it is expressed in the presence of a much higher level of GLP-1R expression (WT islets) or present as homodimer (or monomer) in the islets derived from the GLP-1R( 2/2 ) animals.
Assessment of secretin signaling revealed only very low levels of cAMP production mediated by secretin in both WT and GLP-1R( 2/2 ) islets that were not significantly different in the two groups [ Fig. 8(b) ]. Basal levels of cAMP were also similar for both groups of animals. At the same concentration, GLP-1 was able to promote a greater cAMP response in the WT islets, with no appreciable response in the islets derived from the GLP-1R(
) animals. In islets from both animal strains, secretin was unable to stimulate calcium signaling or insulin secretion in low (2.8 mM) glucose conditions [ Fig. 8(c) and 8(d) ]. In the WT islets, both GLP-1 and secretin promoted glucosemediated calcium signaling; however, GLP-1 was threefold more potent. In contrast to the cAMP studies, secretin potentiated glucose-mediated calcium signaling to a greater degree (relative to ionomycin control) in the GLP-1R( 2/2 ) islets relative to the WT islets [ Fig. 8(c) ]. This is consistent with the greater calcium responses observed in the CHO cells containing SecR alone in comparison with those coexpressed with GLP-1R [ Fig. 5(c) ]. Interestingly, this greater calcium signaling also correlated with enhanced glucose-mediated insulin secretion by secretin in the GLP-1R( 2/2 ) islets relative to the WT controls [ Fig. 8(d) ].
Discussion
Homodimerization of class B GPCRs has been extensively documented (32) and is important for high-affinity agonist binding to the receptor and the efficiency of at least G protein-dependent signaling (6, 7, 15, 32). For three of these receptors, the primary dimeric interface is the lipid-facing domain of TM4, and this is likely to be a common feature of class B receptors (6, 7, 15, 32) . Hetero-association of class B GPCRs has also been widely observed to exist, with reports demonstrating this between SecR and most other class B GPCRs (9, 10) and between GLP-1R and glucose-dependent insulinotropic peptide (GIP) receptor (12) (13) (14) 31) . The molecular basis for and impact on receptor function of hetero-oligomerization is less clear, with varying reports on receptor trafficking, signaling, and stability of dimerization (33) . Furthermore, all studies to date have been in the context of heterologous expression, although these studies have often included saturation experiments to demonstrate that such complexes can exist at low levels of receptor expression. The physiological importance of both homo-and heterodimerization of this receptor class, however, remains to be elucidated.
In the current study we sought to understand the ability of two class B GPCRs, SecR and GLP-1R, which are coexpressed naturally, to form hetero-oligomers, and the importance of this on receptor function. With this goal, we have studied both heterologous expression of the receptors using highly controlled model cell systems, and then confirmed the relevance of heterodimerization of these receptors in pancreatic islets. When each of these receptors was occupied with its natural agonist ligand, it was internalized from the plasma membrane. The ligand for the opposite receptor did not stimulate its internalization when that ligand's natural receptor was not coexpressed on these cells. In contrast, when both receptors were expressed, each ligand was able to stimulate the cointernalization of both receptors.
As previously demonstrated, both SecR and GLP-1R formed homodimers that were dependent on key amino acids on the lipid face of TM4 (6, 7) . In this study, we demonstrated that this interface was also required for heterodimerization of the receptors, indicating that formation of receptor heterodimers would occur competitively with homodimers. In this context, the relative stoichiometry of the receptors and the stability of homovs hetero-oligomers is an important consideration for physiological formation of heterodimers, and we used a range of studies to establish the efficiency of hetero-vs homodimerization and the impact on cellular function.
Both homo-and heterodimers, as established by receptor BRET, were subject to competitive disruption by increasing expression of unlabeled receptors. Of the receptor pairs, SecR homodimers were the most stable; weaker interactions were observed between GLP-1R homodimers and heterodimers, although GLP-1R homodimers were slightly more stable. Consistent with this, peak formation of heterodimers was observed at an approximate 1:1 stoichiometry of GLP-1R to SecR.
To understand the functional importance of heterodimerization, we assayed two key receptor-linked intracellular signaling pathways (cAMP production and intracellular calcium mobilization) in receptor-bearing CHO cell lines, the cellular background most extensively used to understand signaling of these receptors (6, 7) . Stable cells with a constant level of SecR and varying levels of GLP-1R (less than, equal to, and greater than that of SecR) were established and revealed similar levels of cAMP production in response to secretin or GLP-1, when receptors were expressed at similar levels. In contrast, the SecR was more efficiently coupled to intracellular calcium mobilization. When GLP-1R was expressed at levels equal to or greater than that of SecR, conditions that lead to efficient heterodimer formation, there was a selective reduction in secretindependent intracellular calcium mobilization, whereas cAMP production was minimally affected. The greater sensitivity of heterodimerization on intracellular calcium signaling is consistent with observations of the impact of disruption of homodimerization of GLP-1R (7), for which there was greater attenuation of intracellular calcium mobilization compared with cAMP production. The role of dimerization in the observed loss of secretin-dependent intracellular calcium signaling was confirmed in cells expressing equal levels of SecR and the dimer-deficient TM4 mutant of GLP-1R, in which no change to secretin signaling was observed. Of note, as previously observed (7), the parallel disruption of GLP-1R homodimerization in this cell line abolished GLP-1-mediated intracellular calcium mobilization. Collectively, these results establish a potentially important functional role for heterodimerization between SecR and GLP-1R. The differential impact on the two signaling pathways implies that formation of the heterodimer changes the signaling bias of SecR in a manner analogous to that seen for GLP-1R (7). This represents a form of lateral allosteric modulation of SecR function by its physical association with GLP-1R (34) .
Although these initial observations establish the potential importance of heterodimerization, and the stoichiometry of receptor units that would support both formation of the heterodimers and a functional role, these studies are nonetheless confined to heterologous expression systems and do not inform on the importance of the observations in cells naturally expressing the receptors. This lack of physiological correlate to recombinant studies of dimerization among class B GPCRs is true for all studies completed to date (12, 32) . To address this deficiency, we studied receptor function in isolated mouse pancreatic islets.
Secretin stimulates basal or potentiates glucosestimulated insulin secretion when infused into dogs (35-37), mice (38) , and humans (39) (40) (41) (42) (43) (44) (45) (46) (47) . This has been demonstrated to have a direct effect on islets, with secretin-stimulated insulin release demonstrated in a column-perfused isolated mouse pancreatic islet preparation (19, 20) . However, there has been substantial controversy over whether secretin-stimulated insulin secretion is a physiological event (48) . Although the ability of high doses of secretin to elicit these effects makes the pharmacological effect clear, it has been challenging to determine how much secretin to administer to reflect normal physiology. This is a function of difficulties in measuring basal and meal-stimulated secretin in the circulation and, particularly, the inability to define secretin concentrations at its site of action after a meal. This has been partially addressed by infusing a weak acid into the duodenum to stimulate release of endogenous hormone; however, there are reports of this experimental manipulation increasing insulin (40, 43) , as well as having no measurable effect (46, (48) (49) (50) (51) . Furthermore, it is quite possible that increased insulin secretion could be present, yet not measurable in the peripheral circulation, because of hepatic clearance. This was clearly demonstrated by measuring insulin in both portal and peripheral circulations after secretin administration (39) , as well as in duodenal acidification studies in patients with portocaval shunts (52) . However, it seems clear that secretin represents a weaker gut insulinotropic factor than GLP-1 or GIP (53) .
For the purposes of this work, it was only important that the GLP-1R and SecR be coexpressed naturally on a given cell. Pancreatic islets provide this state, on the basis of the observations just reviewed, with the likelihood that b cells are the site of the events being reported. Although secretin has no effect on basal levels of glucagon, its infusion in vivo in the mouse has been reported to increase the glucagon response to cholinergic stimulation (54) . This raises the possibility of an a-cell SecR, but there are no data to suggest the presence of the GLP-1R on that cell (55) , making it an unlikely location for the receptor interaction currently being studied. It is noteworthy that the absolute level of SecR expression on any cells within the islet is quite low, as supported by in situ SecR autoradiography with radioiodinated ligand (18) . The presence of SecR at a very low level was further supported by real-time PCR data in the current report. On the basis of our work with heterologous expression systems, despite the skewed stoichiometric ratio of GLP-1R to SecR, we predicted that SecR/GLP-1R heterodimers would form, and that this heterodimerization would be functionally important. Consistent with the disproportionate expression of SecR and GLP-1R, cAMP production in response to secretin was very low, relative to that seen with GLP-1, and was largely glucose independent. However, despite the lower relative level of SecR, the intracellular calcium response to secretin was only threefold less potent than that to GLP-1, indicating that this pathway is more important for SecR in the context of pancreatic islets; both GLP-1 and secretin responses were glucose dependent. Because the SecR was relatively weakly expressed, compared with the GLP-1R, and the effects of heterodimerization were greater for secretin responses, we used GLP-1R-null mice (27) to determine the functional importance of heterodimerization of the SecR. Loss of GLP-1R did not alter SecR expression or the weak secretindependent cAMP response. In contrast, and consistent with observations in heterologous expression systems, in the absence of GLP-1R, there was an augmented intracellular calcium response to secretin that was paralleled by an enhanced glucose-dependent insulin secretion. Collectively, this work establishes a physiological role for SecR/GLP-1R heterodimerization.
In addition to the importance of dimerization on class B GPCR signaling, heterodimerization has been implicated in receptor trafficking and heterologous internalization by noncanonical peptide agonists (13, 14, 31, 56) ; however, the nature of effect has varied considerably and is likely to be, at least in part, cell background dependent (13, 31) . We observed that coexpression at adequate levels to follow fluorescently tagged constructs of both SecR and GLP-1R was required for heterologous peptide-mediated receptor internalization. Similar effects have been reported in previous studies performed under a variety of conditions with other members of the class B subfamily (56) (57) (58) . Class B GPCRs, like most members of this superfamily, are internalized when occupied by an agonist ligand. In this study, we observe that the nonligand-occupied receptor associated with an occupied receptor can also be internalized when it is part of a heterodimeric receptor complex; both component receptors are internalized together in an agonist-dependent manner. This is likely to have broad, important, functional consequences in regulation and signaling by these heterodimeric vs homodimeric receptor complexes. However, because of the very low level of SecR expression in islets, it is unclear whether secretin stimulation would have a substantial effect on surface GLP-1R, given that one SecR molecule is likely to carry only one GLP-1R molecule with it into the cell.
In the context of pancreatic islets, GLP-1 stimulation is likely to affect SecR responses; however, the large stoichiometric excess of GLP-1R may preclude reciprocal effects. In a report by Roed et al. (31) , the GIP receptor expressed on HEK293 cells or COS cells did not internalize in response to GIP, and the GIP receptor in complex with GLP-1R slowed GLP-1-induced internalization of GLP-1R. This delayed or inhibited internalization of GLP-1R by coexpression of the GIP receptor resulted in reduced signaling by GLP-1R, potentially because a portion of GLP-1-mediated responses were dependent on signaling from internalized receptors. This theme may be different for individual members of this receptor family, in different cell backgrounds or under different conditions. In a separate study (13) , the GIP receptor expressed on HEK293T cells could internalize in response to GIP, and could also interact with GLP-1R, yet stimulation with either natural agonist ligand did not result in the internalization of the other receptor. However, in contrast to the results of Roed et al. (31) , agonist-stimulated disruption of the heteroreceptor complexes was observed, providing an explanation for the lack of trafficking together. It is not yet clear what might explain the differences in these two studies, but the discrepancies could relate to the cellular environment or stoichiometric ratio of the two coexpressed receptors. However, these studies, along with the current study, reveal the potential of heterodimerization to affect trafficking as well as the functional consequences of receptors involved.
In conclusion, our study demonstrates that heterooligomerization of two class B GPCRs can occur at stoichiometrically similar concentrations of receptor and that this is physiologically important for secretin responses in pancreatic islets.
